WO2007138577A3 - Methods of generating a neural tissue using muscle-derived cells - Google Patents
Methods of generating a neural tissue using muscle-derived cells Download PDFInfo
- Publication number
- WO2007138577A3 WO2007138577A3 PCT/IL2007/000637 IL2007000637W WO2007138577A3 WO 2007138577 A3 WO2007138577 A3 WO 2007138577A3 IL 2007000637 W IL2007000637 W IL 2007000637W WO 2007138577 A3 WO2007138577 A3 WO 2007138577A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- muscle
- generating
- methods
- derived cells
- neural tissue
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
- C12N5/0659—Satellite cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Genetics & Genomics (AREA)
- Rheumatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Vascular Medicine (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Use of human myogenic satellite cells for the manufacture of a medicament identified for treating a medical condition of the CNS is provided.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80811206P | 2006-05-25 | 2006-05-25 | |
US60/808,112 | 2006-05-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007138577A2 WO2007138577A2 (en) | 2007-12-06 |
WO2007138577A3 true WO2007138577A3 (en) | 2009-04-23 |
Family
ID=38779083
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL2007/000637 WO2007138577A2 (en) | 2006-05-25 | 2007-05-27 | Methods of generating a neural tissue using muscle-derived cells |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007138577A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102869988B (en) | 2010-08-17 | 2015-09-23 | 泰尔茂株式会社 | Grafted evaluation method |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030124102A1 (en) * | 2001-09-17 | 2003-07-03 | Rudnicki Michael A. | Pax-encoding vector and use thereof |
-
2007
- 2007-05-27 WO PCT/IL2007/000637 patent/WO2007138577A2/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030124102A1 (en) * | 2001-09-17 | 2003-07-03 | Rudnicki Michael A. | Pax-encoding vector and use thereof |
Non-Patent Citations (7)
Also Published As
Publication number | Publication date |
---|---|
WO2007138577A2 (en) | 2007-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1207821A1 (en) | Improved modalities for the treatment of degenerative diseases of the retina | |
NZ603319A (en) | Diabetes therapy | |
HK1215960A1 (en) | Improved modalities for the treatment of degenerative diseases of the retina | |
WO2009031606A1 (en) | Therapeutic and prophylactic agents for arthritis | |
WO2007058842A3 (en) | Medical device with a grooved surface | |
WO2010056302A3 (en) | Iontophoretic therapeutic agent delivery system | |
HK1166263A1 (en) | Use of a foamable composition essentially free of pharmaceutically active ingredients for the treatment of human skin | |
IL198184A0 (en) | Formulations for treatment of adipose tissue, cutaneous tissue and disorders, and muscular tissue | |
WO2007025005A3 (en) | Sustained release formulations of nalbuphine | |
EP2166837A4 (en) | Drug combination for the treatment of skin disorders | |
TW200621730A (en) | Chemical compounds | |
UA99167C2 (en) | Treatment of intervertebral disc degeneration using human umbilical cord tissue-derived cells | |
WO2009040666A3 (en) | Treatment of graft-versus-host disease | |
ZA201200017B (en) | Formulations for the treatment of deeep tissue pain | |
PT2056805E (en) | Use of 2, 5-dihydroxybenzene derivatives for the treatment of tissue reactive diseases | |
WO2011113507A3 (en) | Use of nitrocarboxylic acids for the treatment, diagnosis and prophylaxis of aggressive healing patterns | |
EP2091480A4 (en) | System for the treatment of heart tissue | |
WO2010074936A3 (en) | Enzastaurin for the treatment of cancer | |
EP2063902A4 (en) | Therapeutic cell medicine comprising skin tissue derived stem cell | |
WO2012027324A3 (en) | Treatment for neoplastic diseases | |
NZ595364A (en) | TISSUE KALLIKREIN FOR THE TREATMENT OF PANCREATIC beta-CELL DYSFUNCTION | |
WO2007025229A3 (en) | Compositions and their uses directed to hsp27 | |
WO2008046407A3 (en) | Use of deuterium dioxide for treating hyperproliferative skin diseases | |
WO2008011473A3 (en) | Compositions and their uses directed to hbxip | |
WO2007138577A3 (en) | Methods of generating a neural tissue using muscle-derived cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07736377 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |